tm logo
YUTRIVO
Live/Registered
REGISTERED

on 11 Jul 2023

Last Applicant/ Owned by

Astraallén

Södertälje

SE

SE-15185

Serial Number

90495040 filed on 28th Jan 2021

Registration Number

7102713 registered on 11th Jul 2023

in the Principal Register

Correspondent Address

Cara M. Kearney

Cara M. Kearney

1800 Concord Pike, A2C

Wilmington E 19850-5437

Filing Basis

1. intent to use

Disclaimer

NO DATA

YUTRIVO

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines

Mark Details


Serial Number

No 90495040

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

Yes

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
11th Jul 2023REGISTERE-PRINCIPAL REGISTER
11th Jul 2023NOTICE O REGISTRATION CONIRMATION EMAILE
08th Jun 2023CASE ASSIGNE TO INTENT TO USE PARALEGAL
08th Jun 20231(B) BASIS ELETE; PROCEE TO REGISTRATION
25th Apr 2023TEAS ELETE 1(B) BASIS RECEIVE
25th Apr 2023NOTICE O ALLOWANCE CANCELLE
10th Nov 2022NOTICE O APPROVAL O EXTENSION REQUEST E-MAILE
08th Nov 2022SOU TEAS EXTENSION RECEIVE
08th Nov 2022SOU EXTENSION 1 ILE
08th Nov 2022SOU EXTENSION 1 GRANTE